| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
From the Department of Pathology,* University of Washington, Seattle, Washington; and the Department of Neurology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, People’s Republic of China
Dysregulation of cyclin-dependent kinases (cdks) and cytoskeletal protein hyperphosphorylation characterizes a subset of human neurodegenerative diseases, including Alzheimer’s disease, amyotrophic lateral sclerosis, and Niemann-Pick Type C (NPC). It is thought that these cytoskeletal changes lead eventually to development of hallmark cytoskeletal lesions such as neurofibrillary tangles and axonal spheroids. Although many studies support an involvement of cdks in these neurodegenerative cascades, it is not known whether cdk activity is essential. The naturally occurring npc-1 mutant mouse mimics human NPC, in displaying activation of cdk5, mitotic cdc2, and cdk4, with concomitant cytoskeletal pathology and neurodegeneration. We availed of this model and specific pharmacological inhibitors of cdk activity, to determine whether cdks are necessary for NPC neuropathology. The inhibitors were infused intracerebroventricularly for a 2-week period, initiated at a pathologically incipient stage. While an inactive stereoisomer, iso-olomoucine, was ineffective, two potent inhibitors, roscovitine and olomoucine, attenuated significantly the hyperphosphorylation of neurofilament, tau, and mitotic proteins, reduced the number of spheroids, modulated Purkinje neuron death, and ameliorated motor defects in npc mice. These results suggest that cdk activity is required for neuropathology and subsequent motor impairment in NPC. Studies aimed at knocking down individual cdks in these mice will help identify the specific cdk(s) that are essential, and delineate their precise roles in the neurodegenerative process.
This article has been cited by other articles:
 |
|
 |
|
  C. D. Pacheco, M. J. Elrick, and A. P. Lieberman Tau deletion exacerbates the phenotype of Niemann-Pick type C mice and implicates autophagy in pathogenesis Hum. Mol. Genet., March 1, 2009; 18(5): 956 - 965. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Luo, F. Dou, A. Rodina, S. Chip, J. Kim, Q. Zhao, K. Moulick, J. Aguirre, N. Wu, P. Greengard, et al. Roles of heat-shock protein 90 in maintaining and facilitating the neurodegenerative phenotype in tauopathies PNAS, May 29, 2007; 104(22): 9511 - 9516. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Bitoun, P. L. Oliver, and K. E. Davies The mixed-lineage leukemia fusion partner AF4 stimulates RNA polymerase II transcriptional elongation and mediates coordinated chromatin remodeling Hum. Mol. Genet., January 1, 2007; 16(1): 92 - 106. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. L. Hallows, R. E. Iosif, R. D. Biasell, and I. Vincent p35/p25 is not essential for tau and cytoskeletal pathology or neuronal loss in Niemann-Pick type C disease. J. Neurosci., March 8, 2006; 26(10): 2738 - 2744. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Kitazawa, S. Oddo, T. R. Yamasaki, K. N. Green, and F. M. LaFerla Lipopolysaccharide-Induced Inflammation Exacerbates Tau Pathology by a Cyclin-Dependent Kinase 5-Mediated Pathway in a Transgenic Model of Alzheimer's Disease J. Neurosci., September 28, 2005; 25(39): 8843 - 8853. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Bach, M. Knockaert, J. Reinhardt, O. Lozach, S. Schmitt, B. Baratte, M. Koken, S. P. Coburn, L. Tang, T. Jiang, et al. Roscovitine Targets, Protein Kinases and Pyridoxal Kinase J. Biol. Chem., September 2, 2005; 280(35): 31208 - 31219. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Tang, M.-H. Li, P. Cao, F. Wang, W.-R. Chang, S. Bach, J. Reinhardt, Y. Ferandin, H. Galons, Y. Wan, et al. Crystal Structure of Pyridoxal Kinase in Complex with Roscovitine and Derivatives J. Biol. Chem., September 2, 2005; 280(35): 31220 - 31229. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Shen, D. Nettleton, M. Jiang, S. K. Kim, and J. A. Powell-Coffman Roles of the HIF-1 Hypoxia-inducible Factor during Hypoxia Response in Caenorhabditis elegans J. Biol. Chem., May 27, 2005; 280(21): 20580 - 20588. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. J. Lannutti, N. Blake, M. J. Gandhi, J. A. Reems, and J. G. Drachman Induction of polyploidization in leukemic cell lines and primary bone marrow by Src kinase inhibitor SU6656 Blood, May 15, 2005; 105(10): 3875 - 3878. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
